Reports

ACHP’s annual Report to the Community showcases the work our members are doing to improve health care and strengthen communities, and how ACHP helps them achieve their goals. Our members are well-positioned to guide the future of health care delivery. Read about the exemplary delivery models they have created in their communities.
Rewarding High Quality
04/20/2016

This issue brief builds on the recommendations in ACHP’s Moving Beyond Fee-for-Service brief, and examines how community health plans are designing value-based alternative payment models. It highlights specific, replicable strategies that are designed to reduce the total cost of care and improve health by rewarding providers for quality and specific health outcomes, such as improvedRead more »

diabetes3v2
12/08/2015

ACHP’s infographic series highlights drug cost trends for widely prescribed drugs within various therapeutic classes and communicates the potential effect of these prices on key stakeholders. » Rheumatoid Arthritis (RA) (released in March 2016). Key takeaways include: The annual cost of treating RA in the U.S. is expected to increase by almost 50 percent from 2013 toRead more »

Thumbnail
01/13/2016

This report profiles the work of ACHP member plans, who demonstrate that improving health care involves changing both the way plans work and the communities in which they live.

Capture

Members of the Alliance of Community Health Plans (ACHP) understand the unique role of physician leaders in a rapidly evolving delivery system, and are working hard to both identify them and support their professional development.

Capture
11/10/2015

Telehealth: Helping Patients Access Care When and Where They Need It features six ACHP member plans’ telehealth programs that better manage patients’ health and provide more convenient care, as well as policy recommendations for spreading telehealth innovations to the benefit of patients.

Screenshot
10/22/2015

Medication Therapy Management (MTM) promotes collaboration among pharmacists, patients and providers to establish safe and effective drug regimens for optimal therapeutic outcomes.